Fungal production of eicosapentaenoic and arachidonic acids from industrial waste streams and crude soybean oil
A series of polyunsaturated fatty acids (PUTAs), including 5,8,11,14,17-cis-eicosapentaenoic acid (EPA) and 5,8,lI,14-cis-arachidonic acid (ARA), have widespread nutritional and pharmaceutical value. This study investigated the potential production of the two economically important fatty acids with a fungal fermentation process. The substrates for the fungal fermentation process were crude soybean oil (SBO), a sucrose waste stream (SWS) and a soymeal waste stream (SMW). Glucose (GLU) was used as a substrate in control groups. The microorganisms used were Mortierella elongata NRRL 5513 and Pythium irregulare ATCC 10951.
The use of P. irregulare ATCC 10951 is preferred since it produced high levels and reasonable ratios of EPA and ARA at various temperatures (12, 18, and 24°C). An advantage of P. irregulare was its ability to produce EPA at room temperature, which is desirable for commercial applications. Soybean oil had a unique characteristic of stabilizing pH; the optimal initial pH was 6.0. An emulsifier, Tween 80, allowed much greater dispersion of the SBO in aqueous broth and helped increase EPA and ARA production.
In experiments exploring the combination effects of sugars (1, 2, and 3%) with soybean oil (4%) and Tween 80 (0.2%) at 12, 18, and 24°C, we found that EPA yields of SMW+SBO were significantly higher than those of GLU+SBO and SWS+SBO (P < 0.05). The greatest EPA production (1400 mg/L) was obtained at 12°C (1% SMW, 4% SBO). Cultivation of P. irregulare at reduced temperatures increased lipid unsaturation. An orbital shaker (300 rpm) provided better mixing of SBO and Tween 80 than a water bath shaker did.
The highest ARA level appeared at 18°C-SMW+SB0 (2000 mg/L), which was a statistically interactive temperature-media combination (/'<0.05). Therefore, SMW+SBO other than GLU+SBO or SWS+SBO is suggested when 18°C is used for P. irregulare. The ARA/EPA ratio in this study ranged from 0.2 to 4.0, which would be reasonable for food additive or supplement applications, e.g. infant formula.
uc_id_1qL_u5cBK9GAjggBuDiJ78_NntVMJzIXV_export_download.pdf
11.08 MB
Adobe PDF
36da102d12efabdd29d2ea0273ac417e